-

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Xponential Fitness, Inc. (XPOF)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Xponential Fitness, Inc. (“Xponential” or the “Company”) (NYSE: XPOF). The investigation concerns whether Xponential and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

[Click here to learn more about the investigation]

On March 13, 2025, Xponential issued a press release announcing the Company’s fourth quarter and full year financial results. Xponential reported an unexpected loss for the fourth quarter, as well as a 7.7% year-over-year revenue decline. The press release also announced that Xponential’s Board of Directors had determined that the Company's financial statements for its year ended December 31, 2023 should be restated.

On this news, the price of Xponential shares declined by $4.66 per share, or approximately 38.45%, from $12.12 on March 13, 2025 to close at $7.46 per share on March 14, 2025.

If you purchased or otherwise acquired Xponential securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NYSE:XPOF

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

RICK ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of RCI Hospitality Holdings, Inc. Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired RCI Hospitality Holdings, Inc. (“RCI” or the “Company”) (NASDAQ:RICK) securities during the period of December 15, 2021 through September 16, 2025, inclusive (“the Class Period”). If you suffered a loss on your RCI investments, you have until November 20, 2025 to request lead plaintiff appointment. Follow the link below for more information: [CO...

Kirby McInerney LLP Reminds Nutex Health Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your Nutex investments, you have until October 21, 2025 to request lead plaintiff appointment. Follow the l...

SelectQuote, Inc. INVESTOR ALERT: Kirby McInerney LLP Notifies SelectQuote, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE:SLQT) investors of the October 10, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action. If you purchased or otherwise acquired SelectQuote securities, have information, or would like to learn more, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the form below, to discuss your rights or i...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.